agneta nordberg
agneta nordberg
karolinska institutet, uppala university
Verified email at
Cited by
Cited by
Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
B Winblad, K Palmer, M Kivipelto, V Jelic, L Fratiglioni, LO Wahlund, ...
Journal of internal medicine 256 (3), 240-246, 2004
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
WE Klunk, H Engler, A Nordberg, Y Wang, G Blomqvist, DP Holt, ...
Annals of Neurology: Official Journal of the American Neurological …, 2004
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ...
The Lancet Neurology 13 (6), 614-629, 2014
Defeating Alzheimer's disease and other dementias: a priority for European science and society
B Winblad, P Amouyel, S Andrieu, C Ballard, C Brayne, H Brodaty, ...
The Lancet Neurology 15 (5), 455-532, 2016
Neuronal nicotinic receptors in the human brain
D Paterson, A Nordberg
Progress in neurobiology 61 (1), 75-111, 2000
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
PET imaging of amyloid deposition in patients with mild cognitive impairment
A Forsberg, H Engler, O Almkvist, G Blomquist, G Hagman, A Wall, ...
Neurobiology of aging 29 (10), 1456-1465, 2008
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
H Engler, A Forsberg, O Almkvist, G Blomquist, E Larsson, I Savitcheva, ...
Brain 129 (11), 2856-2866, 2006
PET imaging of amyloid in Alzheimer's disease
A Nordberg
The lancet neurology 3 (9), 519-527, 2004
Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer’s disease
ME Jönhagen, A Nordberg, K Amberla, L Bäckman, T Ebendal, ...
Dementia and geriatric cognitive disorders 9 (5), 246-257, 1998
Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer’s disease
V Jelic, SE Johansson, O Almkvist, M Shigeta, P Julin, A Nordberg, ...
Neurobiology of aging 21 (4), 533-540, 2000
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis
R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ...
Jama 313 (19), 1939-1950, 2015
Cholinesterase inhibitors in the treatment of Alzheimer’s disease
A Nordberg, AL Svensson
Drug safety 19 (6), 465-480, 1998
Nicotinic receptor abnormalities of Alzheimer’s disease: therapeutic implications
A Nordberg
Biological psychiatry 49 (3), 200-210, 2001
Reduced number of [3H] nicotine and [3H] acetylcholine binding sites in the frontal cortex of Alzheimer brains
A Nordberg, B Winblad
Neuroscience letters 72 (1), 115-120, 1986
The use of PET in Alzheimer disease
A Nordberg, JO Rinne, A Kadir, B Långström
Nature Reviews Neurology 6 (2), 78-87, 2010
Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer’s disease
ZZ Guan, X Zhang, R Ravid, A Nordberg
Journal of neurochemistry 74 (1), 237-243, 2000
Decreased protein level of nicotinic receptor α7 subunit in the frontal cortex from schizophrenic brain
ZZ Guan, X Zhang, K Blennow, A Nordberg
Neuroreport 10 (8), 1779-1782, 1999
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment
E Arnaiz, V Jelic, O Almkvist, LO Wahlund, B Winblad, S Valind, ...
Neuroreport 12 (4), 851-855, 2001
Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT)
CG Gottfries, R Adolfsson, SM Aquilonius, A Carlsson, SA Eckernas, ...
Neurobiology of aging 4 (4), 261-271, 1983
The system can't perform the operation now. Try again later.
Articles 1–20